On March 22, 2024, OliX Pharmaceuticals, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,750 KRW | -0.61% | -3.85% | +1.17% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
39,400 KRW | +4.10% | +5.07% | 2.57B | ||
14,750 KRW | -0.61% | -3.85% | 178M | ||
12,700 KRW | +2.17% | +2.42% | 3.19B | ||
8,100 KRW | +7.28% | +9.31% | 3.07B | ||
1st Jan change | Capi. | |
---|---|---|
+1.17% | 178M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- A226950 Stock
- News OliX Pharmaceuticals, Inc
- OliX Pharmaceuticals, Inc announced that it has received KRW 14.7 billion in funding from a group of investors